INFUSYSTEM HOLDINGS, INC Payments to Acquire Businesses, Gross
INFUSYSTEM HOLDINGS, INC (INFU) reported Payments to Acquire Businesses, Gross of $7.65 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2023-03-16
- INFUSYSTEM HOLDINGS, INC payments to acquire businesses, gross for the quarter ending 2022-09-30 was $0.00.
- INFUSYSTEM HOLDINGS, INC payments to acquire businesses, gross for the quarter ending 2021-12-31 was $0.00.
- INFUSYSTEM HOLDINGS, INC payments to acquire businesses, gross for the quarter ending 2021-03-31 was $1.20M.
- INFUSYSTEM HOLDINGS, INC payments to acquire businesses, gross for the quarter ending 2020-03-31 was $0.00.
- INFUSYSTEM HOLDINGS, INC payments to acquire businesses, gross for fiscal 2021 was $7.65M.
- INFUSYSTEM HOLDINGS, INC payments to acquire businesses, gross for fiscal 2020 was $0.00.
- INFUSYSTEM HOLDINGS, INC payments to acquire businesses, gross for fiscal 2019 was $0.00.
- INFUSYSTEM HOLDINGS, INC payments to acquire businesses, gross for fiscal 2016 was $370.00K, a 93.99% decline from fiscal 2015.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 5 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month | Payments to Acquire Businesses, Gross 12 month as first filed |
|---|---|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $7.65M 10-Q · filed 2022-11-08 | ||||
| 2022-06-30 | $7.65M 10-Q · filed 2022-08-04 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $7.65M 10-K · filed 2023-03-16 | $7.98M 10-K · filed 2022-03-15 | |||
| 2021-09-30 | $7.65M 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | $7.65M 10-Q · filed 2021-08-12 | |||||
| 2021-03-31 | $1.20M 10-Q · filed 2021-05-10 | |||||
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 | |||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-10 | |||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-15 | |||||
| 2016-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $370.00K 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | $200.00K 10-Q · filed 2017-11-13 | |||||
| 2015-12-31 | $257.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $2.37M derived: sum of 2 quarters · filed 2017-03-22 | $6.16M 10-K · filed 2017-03-22 | |||
| 2015-09-30 | $2.11M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-12-12 | $5.90M 10-Q · filed 2016-12-12 | ||||
| 2015-06-30 | $3.79M 10-Q/A · filed 2016-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |